Naturalendo Tech Co., Ltd. (KOSDAQ:168330)
South Korea · Delayed Price · Currency is KRW 2,365.00
+25.00 (1.07%)
At close: Sep 23, 2026
Naturalendo Tech Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 22,792 | 22,227 | 22,263 | 18,790 | 13,951 | 14,696 |
Revenue Growth | 0.93% | -0.17% | 18.48% | 34.69% | -5.07% | 10.93% |
Gross Profit Gross Profit Growth | 10,136 | 9,574 | 9,486 | 5,878 | 1,442 | 5,095 |
Operating Income Operating Income Growth | -1,780 | -3,295 | -3,768 | -4,092 | -8,437 | -5,912 |
Net Income Net Income Growth | -1,633 | -3,222 | -3,886 | -4,368 | -10,084 | -5,079 |
Earnings Per Share EPS Growth | -51.71 | -102.03 | -123.08 | -138.35 | -321.05 | -189.02 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cosmetics Cosmetics Growth | 14,588 | 14,710 | 16,720 | 13,179 | 8,849 | 6,001 |
New Natural Drug New Natural Drug Growth | 5,284 | 4,721 | 2,837 | 2,494 | 2,555 | 5,645 |
General Food, Etc. General Food, Etc. Growth | 2,920 | 2,796 | 2,706 | 3,118 | 2,540 | 3,039 |
Total Total Growth | 22,792 | 22,227 | 22,263 | 18,790 | 13,951 | 14,696 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 2,374 | 1,291 | 259.58 | 3,443 | 7,281 | 12,618 |
Total Debt Total Debt Growth | 10,790 | 9,308 | 2,908 | 2,739 | 390.09 | 2,347 |
Net Cash (Debt) Net Cash Growth | -8,416 | -8,016 | -2,649 | 704.55 | 6,891 | 10,271 |
Net Cash Growth | - | - | - | -89.78% | -32.91% | - |
Net Cash Per Share Net Cash Per Share Growth | -266.55 | -253.89 | -83.89 | 22.31 | 219.38 | 382.26 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -4,128 | -5,660 | -2,136 | -3,413 | -4,543 | -3,896 |
Capital Expenditures CapEx Growth | -295.96 | -149.66 | -316.64 | -2,446 | -1,208 | -1,279 |
Free Cash Flow Free Cash Flow Growth | -4,424 | -5,810 | -2,453 | -5,858 | -5,751 | -5,175 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 44.47% | 43.08% | 42.61% | 31.28% | 10.33% | 34.67% |
Operating Margin | -7.81% | -14.82% | -16.93% | -21.78% | -60.48% | -40.23% |
Pretax Margin | -9.22% | -16.29% | -18.31% | -29.85% | -76.64% | -47.56% |
Profit Margin | -7.16% | -14.49% | -17.46% | -23.25% | -72.28% | -34.56% |
FCF Margin | -19.41% | -26.14% | -11.02% | -31.18% | -41.22% | -35.22% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | - | 10.87 | 10.87 | 10.87 | 10.87 | 10.87 |
PS Ratio | 3.28 | 4.40 | 1.92 | 3.37 | 7.36 | 9.55 |